Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.

International journal of rheumatic diseases - 1 Feb 2012

Graf Scott W, Hakendorf Paul, Lester Sue, Patterson Karen, Walker Jenny G, Smith Malcolm D, Ahern Michael J, Roberts-Thomson Peter J

Abstract excerpt

AIM: To investigate the relationship between scleroderma-specific autoantibodies and clinical phenotype and survival in South Australian patients with scleroderma. METHOD: Two cohorts of patients were studied from the South Australian Scleroderma Register (SASR). In the first, the sera of 129 consecutive patients were analyzed for anticentromere (ACA), anti-Scl70, anti-RNA polymerase III, anti-U1RNP, anti-Th/To,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Immunophenotyping

Share to Kaplan-Meier Estimate

Share to Predictive Value of Tests

Share to Registries

Share to South Australia

Source

Identifiers

PMID: 22324953
DOI: 10.1111/j.1756-185X.2011.01688.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.PMID 22324953Read ↗

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.Semantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisSemantic proximity Read ↗

An update on autoantibodies in scleroderma.Semantic proximity Read ↗

Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.Semantic proximity Read ↗

Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification.Semantic proximity Read ↗

Association of anti-RNA polymerase III autoantibodies and cancer in sclerodermaSemantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associationsSemantic proximity Read ↗

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.Semantic proximity Read ↗

Antibodies in scleroderma: Direct pathogenicity and phenotypic associationsSemantic proximity Read ↗

Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.